US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice1

Department of Radiology and Bio-X Program, Stanford University School of Medicine, James H. Clark Center, 318 Campus Dr, East Wing, 1st Floor, Stanford, CA 94305-5427, USA.
Radiology (Impact Factor: 6.21). 02/2008; 246(2):508-18. DOI: 10.1148/radiol.2462070536
Source: PubMed

ABSTRACT To prospectively evaluate contrast material-enhanced ultrasonography (US) with microbubbles targeted to vascular endothelial growth factor receptor type 2 (VEGFR2) for imaging tumor angiogenesis in two murine tumor models.
Animal protocols were approved by the Institutional Administrative Panel on Laboratory Animal Care. A US contrast agent, consisting of encapsulated gaseous microbubbles, was developed specifically to bind to VEGFR2 (by using anti-VEGFR2 antibodies and biotin-streptavidin interaction) which is up-regulated on endothelial cells of tumor blood vessels. VEGFR2-targeted microbubbles (MB(V)), control microbubbles (MB(C)), and nonlabeled microbubbles (MB(N)) were tested for binding specificity on cells expressing VEGFR2 (mouse angiosarcoma SVR cells) and control cells (mouse skeletal myoblast C2C12 cells). Expression of mouse VEGFR2 in culture cells was tested with immunocytochemical and Western blot analysis. Contrast-enhanced US imaging with MB(V) and MB(C) was performed in 28 tumor-bearing nude mice (mouse angiosarcoma, n = 18; rat malignant glioma, n = 10). Differences were calculated by using analysis of variance.
In cell culture, adherence of MB(V) on SVR cells (2.1 microbubbles per SVR cell) was significantly higher than adherence of control microbubbles (0.01-0.10 microbubble per SVR cell; P < .001) and significantly more MB(V) attached to SVR cells than to C2C12 cells (0.15 microbubble per C2C12 cell; P < .001). In vivo, contrast-enhanced US imaging showed significantly higher average video intensity when using MB(V) compared with MB(C) for angiosarcoma and malignant glioma tumors (P < .001). Results of immunohistochemical analysis confirmed VEGFR2 expression on vascular endothelial cells of both tumor types.
US imaging with contrast microbubbles targeted to VEGFR2 allows noninvasive visualization of VEGFR2 expression in tumor vessels in mice.

  • Source
    • "In ultrasound active targeting contrast imaging, antibodies, peptides, or other molecules are attached to microbubble shell. Some examples include lipid shell microbubbles attached anti-OCAM-1 monocolonal antibody for imaging acute cardiac allograft transplant rejection in rats, microbubbles targeted to vascular endothelial growth factor receptor type 2 (VEGFR2) for imaging tumor angiogenesis in murine tumor models and microbubbles with RGD peptide for thrombosis and angiogenesis targeting [46]–[48]. Also, feasibility of using recombinant human adenoviral vectors to detect nodal metastases of prostate cancer was demonstrated with adenovirus-mediated gene expression PET imaging [49] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lymphatic vessels are a part of the circulatory system in vertebrates that maintain tissue fluid homeostasis and drain excess fluid and large cells that cannot easily find their way back into venous system. Due to the lack of noninvasive monitoring tools, lymphatic vessels are known as forgotten circulation. However, the lymphatic system plays an important role in diseases such as cancer and inflammatory conditions. In this paper, we start to briefly review the current existing methods for imaging lymphatic vessels, mostly involving dye/targeting cell injection. We then show the capability of optical coherence tomography (OCT) for label-free noninvasive in vivo imaging of lymph vessels and nodes. One of the advantages of using OCT over other imaging modalities is its ability to assess label-free blood flow perfusion that can be simultaneously observed along with lymphatic vessels for imaging the microcirculatory system within tissue beds. Imaging the microcirculatory system including blood and lymphatic vessels can be utilized for imaging and better understanding pathologic mechanisms and the treatment technique development in some critical diseases such as inflammation, malignant cancer angiogenesis, and metastasis.
    IEEE Journal of Selected Topics in Quantum Electronics 03/2014; 20(2):6800510-6800510. DOI:10.1109/JSTQE.2013.2278073 · 3.47 Impact Factor
  • Source
    • "genesis pathway in primary tumors and from the vasculogenesis pathway in recurrent tumors . The vasculature of a tumor is an important determinant for evaluating its clinical behavior in terms of the tumor growth , invasiveness and metastatic potentials and thera - peutic response ( Jugold et al . 2008 ; Kozin et al . 2007 ; Rofstad et al . 2005 ; Willmann et al . 2008 ) . Currently , combined anti - angiogenesis and radiotherapy has shown the synergistic effect for inhibiting primary tumor growth , but not for recurrent tumors ( Chen et al . 2011a ; Kioi et al . 2010 ) . Thus , recent studies have investigated how to improve the curability of recurrent tumors by Fig . 3 . Representative 2 - D cross -"
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this preclinical study was to perform a longitudinal investigation of the function and morphology of the vasculatures of primary and recurrent tumors, because recurrent tumors have lower curability. Thus, elucidating differences in the features of the vasculatures of primary and recurrent tumors could help to improve tumor therapies. The transgenic adenocarcinoma of the mouse prostate tumors were transplanted in nonirradiated and with 25 Gy of preirradiation normal tissues to produce the primary and recurrent tumor models, respectively. The perfusion and branching index of tumor vasculatures were characterized to reveal the function and morphology information, respectively. The blood vessels were more dilated and continuous in recurrent tumors than in primary tumors. During tumor progression, the perfusion increased in primary tumors but did not change significantly in recurrent tumors. The tumor perfusion was lower in recurrent tumors than in primary tumors, whereas branching index in 2-D ultrasound images did not differ between the two tumor models. Furthermore, the introducing 3-D volumetric power Doppler image may have the potential for accurately revealing the morphologic features within tumors. The results of this study suggest that power Doppler imaging is an easily applied and rapid method for noninvasively assessing the vascular features of primary and recurrent tumors and for exploring differences between their vasculature pathways.
    Ultrasound in medicine & biology 02/2013; DOI:10.1016/j.ultrasmedbio.2012.11.005 · 2.10 Impact Factor
  • Source
    • "This sequence has been widely used to quantify targeted MB binding in vivo because it allows for direct measurement of MB accumulation in the vessels. Adherent MBs are quantitatively assessed by subtracting post-flash intensities from the pre-flash intensities (Willmann et al. 2008). By modulating the Ad-HA-hSSTr2-GFP vector dose, expression of the exogenous cellular receptor (HA protein) within the tumor at low and high concentrations was achieved (Zinn et al. 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reported in this study is an animal model system for evaluating targeted ultrasound (US) contrast agents binding using adenoviral (Ad) vectors to modulate cellular receptor expression. An Ad vector encoding an extracellular hemagglutinin (HA) epitope tag and a green fluorescent protein (GFP) reporter was used to regulate receptor expression. A low and high receptor density (in breast cancer tumor bearing mice) was achieved by varying the Ad dose with a low plaque forming unit (PFU) on day 1 and high PFU on day 2 of experimentation. Targeted US contrast agents, or microbubbles (MB), were created by conjugating either biotinylated anti-HA or IgG isotype control antibodies to the MB surface with biotin-streptavidin linkage. Targeted and control MBs were administered on both days of experimentation and contrast-enhanced US (CEUS) was performed on each mouse using MB flash destruction technique. Signal intensities from MBs retained within tumor vasculature were analyzed through a custom Matlab program. Results showed intratumoral enhancement attributable to targeted MB accumulation was significantly increased from the low Ad vector dosing and the high Ad vector dosing (p = 0.001). Control MBs showed no significant differences between day 1 and day 2 imaging (p = 0.96). Additionally, targeted MBs showed a 10.5-fold increase in intratumoral image intensity on day 1 and an 18.8-fold increase in image intensity on day 2 compared with their control MB counterparts.
    Ultrasound in medicine & biology 11/2012; 39(1). DOI:10.1016/j.ultrasmedbio.2012.08.016 · 2.10 Impact Factor
Show more

Preview (3 Sources)

Available from